IBIO
iBio, Inc.
1.10$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +4.1% | -15.4% | -1.1% | +1.1% | +0.4% | +1.1% | +1.4% | -173.0% | – | -11.6% | – | |
| – | -40.4% | +0.2% | -21.2% | +15.3% | +14.5% | -22.1% | -27.0% | +19.6% | -21.7% | +49.0% | +11.4% | – | |
| – | – | – | – | – | – | – | -99.3% | -6,712.5% | – | -275.9% | – | – | |
| – | – | – | – | -100.0% | – | +1,300.0% | -92.9% | +3,100.0% | +1,512.5% | -97.9% | +72.7% | – | |
| – | – | – | -114.4% | – | -100.3% | +600.0% | – | -47,862.2% | -86.1% | +4.3% | +41.8% | – | |
| – | – | +457.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +2.4% | +3.5% | +4.0% | -12.6% | +283.8% | -100.0% | – | – | |
| – | +62.0% | +25.5% | +158.5% | -101.2% | -6.2% | – | +669.5% | +471.0% | -81.2% | +220.5% | -31.1% | – | |
| – | – | – | +237.2% | -139.6% | – | – | – | +441.5% | -97.1% | +3,279.5% | -53.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.